Camille Dumont

Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity

Vincent Jannin, Stéphanie Chevrier, Matthieu Michenaud et al. · International Journal of Pharmaceutics · 2015 · 56 citations

Lipid Preparation, Lipid Formulations, Microemulsion +3

In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract

Camille Dumont, Sandrine Bourgeois, Hatem Fessi et al. · International Journal of Pharmaceutics · 2019 · 47 citations

Nanoparticles, Nanomedicine, Lipid Preparation +9

A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations

Bryce W. Barber, Camille Dumont, Philippe Caisse et al. · Pharmaceutics · 2021 · 29 citations · Full text

Tissue Engineering, Engineering, Biofabrication +19

Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura

Camille Dumont, Aïcha Mérouani, Thiérry Ducruet et al. · Pediatric Nephrology · 2020 · 26 citations

Glomerular Disease, Glomerulonephritis, Henoch-schönlein Purpura +8

Self-emulsifying drug delivery systems (SEDDS): In vivo-proof of concept for oral delivery of insulin glargine

Victor Claus, Helen Spleis, Christoph Federer et al. · International Journal of Pharmaceutics · 2023 · 24 citations · Full text